These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32566037)

  • 1. MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer.
    Ye ZQ; Zou CL; Chen HB; Jiang MJ; Mei Z; Gu DN
    Dis Markers; 2020; 2020():2782101. PubMed ID: 32566037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.
    Wang P; Zhuang L; Zhang J; Fan J; Luo J; Chen H; Wang K; Liu L; Chen Z; Meng Z
    Mol Oncol; 2013 Jun; 7(3):334-45. PubMed ID: 23177026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.
    Miyamae M; Komatsu S; Ichikawa D; Kawaguchi T; Hirajima S; Okajima W; Ohashi T; Imamura T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
    Br J Cancer; 2015 Nov; 113(10):1467-76. PubMed ID: 26505678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
    Song WF; Wang L; Huang WY; Cai X; Cui JJ; Wang LW
    Asian Pac J Cancer Prev; 2013; 14(12):7529-36. PubMed ID: 24460329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.
    Ohuchida K; Mizumoto K; Kayashima T; Fujita H; Moriyama T; Ohtsuka T; Ueda J; Nagai E; Hashizume M; Tanaka M
    Ann Surg Oncol; 2011 Aug; 18(8):2381-7. PubMed ID: 21347785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
    Giovannetti E; Funel N; Peters GJ; Del Chiaro M; Erozenci LA; Vasile E; Leon LG; Pollina LE; Groen A; Falcone A; Danesi R; Campani D; Verheul HM; Boggi U
    Cancer Res; 2010 Jun; 70(11):4528-38. PubMed ID: 20460539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
    Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
    Shi W; Zhang C; Ning Z; Hua Y; Li Y; Chen L; Liu L; Chen Z; Meng Z
    J Exp Clin Cancer Res; 2019 Feb; 38(1):60. PubMed ID: 30728036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.
    Hasegawa S; Eguchi H; Nagano H; Konno M; Tomimaru Y; Wada H; Hama N; Kawamoto K; Kobayashi S; Nishida N; Koseki J; Nishimura T; Gotoh N; Ohno S; Yabuta N; Nojima H; Mori M; Doki Y; Ishii H
    Br J Cancer; 2014 Oct; 111(8):1572-80. PubMed ID: 25117811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-200b and -301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells.
    Funamizu N; Lacy CR; Kamada M; Yanaga K; Manome Y
    Int J Oncol; 2019 Mar; 54(3):991-1000. PubMed ID: 30628651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
    Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL17RB expression might predict prognosis and benefit from gemcitabine in patients with resectable pancreatic cancer.
    Song Y; Ji B; Jiang CX; Chen ZM; Yao NH; Mukaida N; Huang H
    Pathol Res Pract; 2019 Dec; 215(12):152650. PubMed ID: 31585811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.
    Iwagami Y; Eguchi H; Nagano H; Akita H; Hama N; Wada H; Kawamoto K; Kobayashi S; Tomokuni A; Tomimaru Y; Mori M; Doki Y
    Br J Cancer; 2013 Jul; 109(2):502-11. PubMed ID: 23799850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.
    Maréchal R; Demols A; Gay F; De Maertelaere V; Arvanitaki M; Hendlisz A; Van Laethem JL
    Oncology; 2007; 73(1-2):41-51. PubMed ID: 18334830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
    Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels.
    Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.
    LaConti JJ; Shivapurkar N; Preet A; Deslattes Mays A; Peran I; Kim SE; Marshall JL; Riegel AT; Wellstein A
    PLoS One; 2011; 6(6):e20687. PubMed ID: 21738581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
    Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.
    Zhang X; Zhao P; Wang C; Xin B
    Biochem Biophys Res Commun; 2019 Mar; 510(4):508-514. PubMed ID: 30737032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.